The groundbreaking approach of the medication represents a significant development in the management of the condition. Unlike existing medications, tirzepatide affects two pathways – the GLP-1 hormone and the GIP https://tirzepatidepeptide692221.tusblogos.com/42767452/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment